1) Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism - PMID: 35017197
2) Risk assessment with gut microbiome and metabolite markers in NAFLD development - PMID: 35675435
3) Microbiome and metabolome features of the cardiometabolic disease spectrum - PMID: 35177860
4) Statin therapy is associated with lower prevalence of gut microbiota dysbiosis - PMID: 32433607
5) Interpretable and accurate prediction models for metagenomics data - PMID: 32150601